Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1135-1145

  Wanikiat, P ^a   Woodward, D F ^b   Armstrong, R A ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ALLERGAN INC   (United States)

^c QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Chemotaxis; Cyclic GMP; G kinase; Guanylyl cyclase; Neutrophils; Nitric oxide; Nitric oxide synthase; Phospholipase D; Superoxide anion

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; 6 ANILINO 5,8 QUINOLINEQUINONE; CANAVANINE; CYCLIC GMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GUANYLATE CYCLASE; KT 5823; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PHOSPHOLIPASE D; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE INHIBITOR; SCAVENGER; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

CELL DEGRANULATION; CHEMOTAXIS, LEUKOCYTE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GUANYLATE CYCLASE; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; SUPEROXIDES;

EID: 0030777635     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701477     Document Type: Article

References (55)

1. AKAIKE, T., YOSHIDA, M., MIYAMOTO, Y., SATO, K., KOHNO, M., SASAMOTO, K., MIYAZAKI, K., UEDA, S. & MAEDA, H. (1993). Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry, 32, 827-832.
2. AMATRUDA, T.T., GERALD, N.P., GERALD, C. & SIMON, M.I. (1993). Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem., 268, 10139-10144.
3. ANDERSON, R., GLOVER, A., KOORNHOF, H.J. & RABSON, A.R. (1986). In vitro stimulation of neutrophil motility by levamisole: maintenance of cyclic GMP levels in chemotactically stimulated levamisole-treated neutrophils. J. Immunol., 117, 28-432.
4. 2 and selective EP agonists on chemotaxis of human neutrophils. Br. J. Pharmacol., 116, 2903-2980.
5. BARTEN, A.D., RYDER, K., LOURENCO, R.V., DRALLE, W. & WEISS, S.G. (1976). Inflammatory reaction and airway damage in cystic fibrosis. J. Lab. Clin. Med., 88, 423-426.
6. BEAUVAIS, F., MICHEL, L. &. DUBERTRET, L. (1995). Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J. Cell. Physiol., 165, 610-614.
7. BEDNAR, M.M., BALAZY, M., MURPHY, M., BOOTH, C., FULLER, S.P., BARTON, A., BINGHAM, J., GOLDING, L. & GROSS, C.E. (1996). Peroxynitrite augments fMLP-stimulated chemiluminescence by neutrophils in human whole blood. J. Leukocyte Biol., 60, 619-624.
8. BELENKY, S.N., ROBBINS, R.A., RENNARD, S.I., GOSSMAN, G.L., NELSON, K.J. & RUBINSTEIN, I. (1993). Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J. Lab. Clin. Med., 122, 388-394.
9. BILLAH, M.M., ECKEL, S., MULLMANN, T.J., ERGAN, R.W. & SIEGEL, M.I. (1989). Phosphatidylcholine hydrolysis by PLD determines the phophatidate and diglyceride levels in chemotactic peptide stimulated neutrophils. J. Biol. Chem., 264, 17069-17077.
10. BILLAH, M.M. & ANTHES, J.C. (1990). The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J., 269, 281-291.
11. BONSER, R.W., THOMSON, N.T., RANDALL, R.W. & GARLAND, L.G. (1989). Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem. J., 264, 617-620.
12. BUTT, E., EIGENTHALER, M. & GENIESER, H.G. (1994). (RP)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol., 269, 265-268.
13. CASSIMERIS, L. & ZIGMOND, S.H. (1990). Chemotractant stimulation of polymorpho-leukocyte locomotion. Semin. Cell. Biol., 1, 125-134.
14. CATERINA, M.J. & DEVREOTES, P.N. (1991). Molecular insights into eukariotic chemotaxis. FASEB J., 5, 3078-3085.
15. CLANCY, R.M., LESZCZYNSKA-PIZIAK, J. & AMBRASON, S.B. (1992). Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest., 90, 1116-1121.
16. CLANCY, R., LESZCZYNSKY, J., AMIN, A., LEVARTOVSKY, D. & ABRAMSON, S.B. (1995). Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J. Leukocyte Biol., 58, 196-202.
17. FEELISCH, M., OSTROWSKI, J. & NOACK, E. (1989). On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol., 14, (Suppl. 11), S13-S22.
18. FEELISCH, M. (1991). The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol., 17, (Suppl. 3), S25-S33.
19. GAUDRY, M., CAON, A.C., GILBERT, C., LILLE, S. & NACCACHE, P.H. (1992). Evidence for the involvement of tyrosine kinases in the locomotory response in human neutrophils. J. Leukocyte Biol., 51, 103-108.
20. GRYGLEWSKI, R.J., KORBUT, R., KALECINSKA, A. & ZEMBOWICZ, A. (1986). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454-456.
21. IHA, S., ORITA, K., KANNO, T., UTSUMI, T., SATO, E.F., INOUE, M. & UTSUMI, K. (1996). Oxygen-dependent inhibition of neutrophil respiratory burst by nitric oxide. Free Radical Res., 25, 489-498.
22. KADOTA, K., YUI, Y., HATTORI, R., UCHIZUMI, H. & KAWAI, C. (1991). A new relaxing factor in supernatant of incubated rat peritoneal neutrophils. Am. J. Physiol., 260, H967-H972.
23. KANAHO, Y., NAKAI, Y., KATOH, M. & NOZAWA, Y. (1993). The phosphatase inhibitor 2,3-diphosphoglycerate interferes with phospholipase D activation in rabbit peritoneal neutrophils. J. Biol. Chem., 268, 12492-12497.
24. G-monomethyl-L-arginine: A role for cyclic GMP. Blood, 74, 1885-1887.
25. KASE, H., IWAHASHI, K., NAKAISHI, S., MATSUDA, Y., YAMADA, K., TAKAHASHI, M., MURAKATA, C., SATO, A. & KANEKO, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun., 142, 436-440.
26. KENAKIN, T.P. (1987). Functional antagonism and synergism. In Pharmacologic Analysis of Drug Receptor Interaction, pp. 245-257. New York: Raven Press.
27. KUBES, P., SUZUKI, M. & GRANDER, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
28. LEE, D.K.H., FAUNCE, D., HENRY, D., STURM, R.J. & RIMELE, T. (1990). Neutrophil-derived relaxing factor relaxes vascular smooth muscle through a cGMP-mediated mechanism. Life Sci., 46, 1531-1538.
29. LOPEZ FARRE, A., RIESCO, A., MOLIZ, M., EGIDO, J., CASADO, S., HERNANDO, L. & CARAMELO, C. (1991). Inhibition of L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils. Biochem. Biophys. Res. Commun., 178, 884-891.
30. MCCALL, T.B., BOUGHTON-SMITH, N.K., PALMER, R.M.J. & MONCADA, S. (1989). Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem. J., 261, 283-286.
31. MEHTA, J.L., LAWSON, D.L., NICOLINI, F.A., CAIN, D.A., METHA, P. & SCHREIER, H. (1990). Evidence for generation of a large amount of nitric oxide-like vascular smooth muscle relaxant by cholesterol-rich neutrophils. Biochem. Biophys. Res. Commun., 173, 438-442.
32. MOILANEN, E., VUORINEN, P., KANKAANRANTA, H., METSAKETELA, T. & VAPAATALO, H. (1993). Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol., 109, 852-858.
33. MONCADA, S. & HIGGS, E.A. (1991). Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest., 21, 361-374.
34. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
35. MYERS, P.R., MINOR, Jr, R.L., GUERRA, Jr, R., BATES, J.N. & HARRILSON, D.G. (1990). Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature, 345, 151-163.
36. 4 release from human PMN may mediated by cyclic GMP. Eicosanoids, 3, 243-245.
37. PRYZWANSKY, K.B., WYATT, T.A., NICHOLS, H. & LINCOLN, T.M. (1990). Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. Blood, 76, 612-618.
38. RIMELE, T.J., STURM, R.J., ADAMS, L.M., HENRY, D.E., HEASLIP, R.J., WEICHMAN, B.M. & GRIMES, D. (1988). Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J. Pharmacol. Exp. Ther., 245, 102-111.
39. RIMELE, T.J., ARMSTRONG, S.J., GRIMES, D. & STRUM, R.J. (1991). Rat peritoneal neutrophils selectively relax vascular smooth muscle. J. Pharmacol. Exp. Ther., 258, 963-971.
40. SALVEMINI, D., DENUCCI, G., GRYGLEWSKI, R.J. & VANE, J.R. (1989). Human neutrophils and mononeuclear cells inhibit platelet aggregation by releasing a nitric-oxide like factor. Proc. Natl. Acad. Sci. U.S.A., 86, 6328-6332.
41. SANDLER, J.A., GALLIN, J.I. & VAUGHN, M. (1975). Effect of serotonin, carbamylcholine, and ascorbic acid on leukocyte cyclic GMP and chemotaxis. J. Cell. Biol., 67, 480-484.
42. 4. FEBS Lett., 244, 357-360.
43. SCHRODER, H., NEY, P., WODITSCH, I. & SCHROR, K. (1990). Cyclic GMP mediated SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur. J. Pharmacol., 182, 211-218.
44. SMITH, R.J. & IGNARRO, L.J. (1975). Bioregulation of enzyme secretion from human neutrophils: roles of guanosine 3′:5′-monophosphate and calcium in stimulus-secretion coupling. Proc. Natl. Acad. Sci. U.S.A., 72, 108-112.
45. STEPHENS, R.J. & SNYDERMAN, R. (1982). Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes. J. Immunol., 28, 1192-1197.
46. TALPAIN, E., ARMSTRONG, R.A., COLEMAN, R.A. & VARDEY, C.J. (1995). Characterisation of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br. J. Pharmacol., 114, 1459-1465.
47. VAN UFFLELEN, B.E., DE KOSTER, B.M., VAN DEN BROEK, P.J., VANSTEVENINCK, J. & ELFERINK, J.G. (1996). Modulation of neutrophil migration by exogenous gaseous nitric oxide. J. Leukocyte Biol., 60, 94-100.
48. WEISS, S.J. (1989). Tissue destruction by neutrophils. N. Engl. J. Med., 320, 813-819.
49. WENZEL-SEIFERT, K., ERVENS, J. & SEIFERT, R. (1991). Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 396-402.
50. WRIGHT, C.D., MULSCH, A., BUSSE, R. & OSSWALD, H. (1989). Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun., 160, 813-819.
51. WYATT, T.T., LINCOLN, T.M. & PRYZWANSKY, K.B. (1990). Compartmentalization of cyclic GMP-dependent protein kinase (G-kinase) in calcium ionophore and phorbol ester stimulated human neutrophils. FASEB J., 4, A872.
52. WYATT, T.A., LINCOLN, T.M. & PRYZWANSKY, K.B. (1991). Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. J. Biol. Chem., 266, 21274-21280.
53. WYATT, T.A. & PRYZWANSKY, K.B. (1991). KT 5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res. Commun. Chem. Pathol. Pharmacol., 74, 3-13.
54. WYATT, T.A., LINCOLN, T.M. & PRYZWANSKY, K.B. (1993). Regulation of human neutrophil degradation by LY-83583 and L-arginine: role of cGMP-dependent protein kinase. Am. J. Physiol., 265, C201-C211.
55. YUI, Y., HATTORI, R., KOSUGA, K., EIZAWA, H., HIKI, K., OHKAWA, S., OHNISHI, K., TERAO, S. & KAWAI, C. (1991). Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils. J. Biol. Chem., 266, 3369-3371.